Category: Biotech

February 16, 2023 at 2:48 pm

Fusion Pharmaceuticals Acquires Investigational New Drug

Fusion Pharmaceuticals (Nasdaq: FUSN) has broadened its oncology pipeline with the acquisition of a Phase 2 program for a radiopharmaceutical targeting metastatic castrate resistant prostate… [Read More]

February 14, 2023 at 4:35 pm

Incannex Healthcare Achieves Interim Milestone in Phase 2 Psilocybin Clinical Trial

Australian pharmaceutical company, Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), has achieved its interim milestone of 29 patients completing primary endpoint assessments in a Phase… [Read More]

February 10, 2023 at 1:42 pm

Gracell Biotechnologies Receives FDA Clearance of IND Application for Phase 1b/2 Clinical Trial

Gracell Biotechnologies (Nasdaq: GRCL), a global clinical-stage biopharmaceutical company, has received FDA clearance for its IND application, clearing the company to initiate a clinical trial… [Read More]

February 09, 2023 at 9:05 am

HeartSciences Secures Korean Patent for Innovative Heart Disease Detection Device

Medical technology company, Heart Test Laboratories (d/b/a HeartSciences) (Nasdaq: HSCS), has been granted a patent by the Korean Intellectual Property Office. HeartSciences is focused on… [Read More]